The State of AI in Clinical Trials — 2026 Report

Supplied by Medidata Solutions on Wednesday, 12 August, 2026


AI is moving beyond experimentation in clinical research. See how early adopters are improving trial performance, overcoming scaling barriers, and unlocking the next generation of AI-driven clinical development.


What’s inside the 2026 report:

·Early Adopter Advantage: Where AI leaders are seeing the biggest gains.

·AI in Action: Key areas where AI is delivering measurable results today.

·Scaling Success: The barriers to enterprise-wide adoption — and how to overcome them.

·What’s Next: Emerging trends, from protocol simulation to autonomous agents.


Related White Papers

SARS-Cov-2 variants with spike protein gene mutations

Learn about innovative SARS-Cov-2 tests that...

Hospital intelligence surges with new smart technology

Learn how to leverage the latest technology to create new and better clinical processes and...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd